- Exchange: Tokyo
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Large Pharmaceuticals
Daiichi Sankyo Co Ltd
+ Add to Watchlist4568:JP
1,610 JPY 10 0.63%As of 02:00:00 ET on 06/19/2013.
Snapshot for Daiichi Sankyo Co Ltd (4568)
| Open: | 1,621 | Day's Range: | 1,598 - 1,648 | Volume: | 2,700,700 |
|---|---|---|---|---|---|
| Previous Close: | 1,600 | 52wk Range: | 1,168 - 2,014 | 1-Yr Rtn: | +34.48% |
Key Statistics for 4568
| Current P/E Ratio (ttm) | 17.0118 |
|---|---|
| Estimated P/E(03/2014) | 16.0778 |
| Relative P/E vs. TPX | 0.8074 |
| Earnings Per Share (JPY) (ttm) | 94.6400 |
| Est. EPS (JPY) (03/2014) | 100.1380 |
| Est. PEG Ratio | 5.8465 |
| Market Cap (M JPY) | 1,141,508.25 |
| Shares Outstanding (M) | 709.01 |
| 30 Day Average Volume | 3,405,987 |
| Price/Book (mrq) | 1.2781 |
| Price/Sale (ttm) | 1.1355 |
| Dividend Indicated Gross Yield | 3.73% |
| Cash Dividend (JPY) | 30.0000 |
| Last Dividend | 09/26/2013 |
| 5 Year Dividend Growth | -3.04% |
| Next Earnings Announcement | 07/31/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4568
Company Profile & Key Executives for 4568
DAIICHI SANKYO COMPANY, LIMITED is a holding company established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals.
| Takashi ShodaChairman | Joji NakayamaPresident/CEO |
| Tsutomu UneExecutive Director | Takeshi OgitaSenior Executive Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
4568 News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page